R

RGC

Regencell Bioscience Holdings Limited
HealthcareDrug Manufacturers - Specialty & Generic|NASDAQ Capital Market|HK

Price

$30.80

Market Cap

$15.23B

Beta

2.25

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-100.00%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio
FCF Yield-0.03%
Debt / Equity0.11
Interest Coverage999.0x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for RGC.

RGC — Regencell Bioscience Holdings Limited Stock Analysis | Tessera Alpha